IC
REGN icon

IEQ Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

IEQ Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.5M Buy
78,302
+9,665
+14% +$7.4M 0.28% 66
2025
Q4 		$53M Buy
68,637
+24,977
+57% +$17M 0.16% 77
2025
Q3 		$24.5M Buy
43,660
+39,747
+1,016% +$22.5M 0.07% 138
2025
Q2 		$2.05M Sell
3,913
-4,306
-52% -$2.4M 0.01% 634
2025
Q1 		$5.21M Buy
8,219
+4,381
+114% +$3.01M 0.04% 332
2024
Q4 		$2.73M Sell
3,838
-1,496
-28% -$1.26M 0.03% 422
2024
Q3 		$5.61M Sell
5,334
-197
-4% -$219K 0.07% 183
2024
Q2 		$5.81M Buy
5,531
+507
+10% +$491K 0.08% 164
2024
Q1 		$4.84M Buy
5,024
+585
+13% +$556K 0.07% 185
2023
Q4 		$3.9M Buy
4,439
+990
+29% +$815K 0.06% 188
2023
Q3 		$2.84M Buy
3,449
+103
+3% +$80.9K 0.06% 201
2023
Q2 		$2.4M Buy
3,346
+73
+2% +$56.3K 0.05% 235
2023
Q1 		$2.69M Sell
3,273
-299
-8% -$226K 0.06% 205
2022
Q4 		$2.58M Buy
3,572
+336
+10% +$248K 0.07% 198
2022
Q3 		$2.23M Buy
3,236
+744
+30% +$468K 0.06% 213
2022
Q2 		$1.47M Buy
2,492
+324
+15% +$211K 0.04% 246
2022
Q1 		$1.51M Buy
2,168
+407
+23% +$257K 0.04% 255
2021
Q4 		$1.11M Sell
1,761
-63
-3% -$38.7K 0.03% 285
2021
Q3 		$1.1M Buy
1,824
+819
+81% +$508K 0.03% 281
2021
Q2 		$561K Buy
1,005
+427
+74% +$216K 0.02% 342
2021
Q1 		$273K Buy
+578
New +$281K 0.01% 383
2020
Q4 		– Sell
-767
Closed -$429K – 354
2020
Q3 		$429K Buy
767
+1
+0.1% +$606 0.02% 252
2020
Q2 		$478K Hold
766
– – 0.03% 204
2020
Q1 		$373K Buy
766
+94
+14% +$38.8K 0.03% 244
2019
Q4 		$253K Buy
+672
New +$226K 0.02% 345

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IEQ Capital's REGN Position: Q1 2026 in Review

IEQ Capital increased its Regeneron Pharmaceuticals (REGN) stake by 14% in Q1 2026, buying an estimated $7.4M and bringing the position to 78,302 shares worth $60.5M. The position accounts for 0.28% of the portfolio, ranked #66.

IEQ Capital first reported a position in REGN in Q4 2019 and has held it in 25 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • IEQ Capital held 78,302 shares of Regeneron Pharmaceuticals worth $60.5M as of Q1 2026.
  • IEQ Capital bought 9,665 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $7.4M.
  • Regeneron Pharmaceuticals made up 0.28% of IEQ Capital's portfolio in Q1 2026, its #66 holding.
  • IEQ Capital first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 25 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.